Compounds > s20098
Page last updated: 2024-08-25

s20098 and Obesity

s20098 has been researched along with Obesity in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Lungkaphin, A; Pengrattanachot, N; Phengpol, N; Promsan, S; Sutthasupha, P; Thongnak, L1
Algieri, F; Diez-Echave, P; Duarte, J; Gálvez, J; García, F; Garrido-Mesa, J; Hidalgo-García, L; Morón, R; Rodríguez-Cabezas, ME; Rodríguez-Nogales, A; Romero, M; Ruiz-Malagón, AJ; Sánchez, M; Toral, M; Vezza, T1
Cherngwelling, R; Lungkaphin, A; Pengrattanachot, N; Phengpol, N; Promsan, S; Sutthasupha, P; Swe, MT; Thongnak, L1
Howland, RH1

Other Studies

4 other study(ies) available for s20098 and Obesity

ArticleYear
Agomelatine, a structural analog of melatonin, improves kidney dysfunction through regulating the AMPK/mTOR signaling pathway to promote autophagy in obese rats.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2022, Volume: 165

    Topics: Acetamides; AMP-Activated Protein Kinases; Animals; Autophagy; Insulin Resistance; Kidney; Male; Melatonin; Naphthalenes; Obesity; Rats; Rats, Wistar; Signal Transduction; TOR Serine-Threonine Kinases

2022
The melatonergic agonist agomelatine ameliorates high fat diet-induced obesity in mice through the modulation of the gut microbiome.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 153

    Topics: Acetamides; Animals; Diet, High-Fat; Dysbiosis; Gastrointestinal Microbiome; Humans; Male; Melatonin; Mice; Mice, Inbred C57BL; Naphthalenes; Obesity

2022
Agomelatine protects against obesity-induced renal injury by inhibiting endoplasmic reticulum stress/apoptosis pathway in rats.
    Toxicology and applied pharmacology, 2021, 08-15, Volume: 425

    Topics: Acetamides; Animals; Apoptosis; Diet, High-Fat; Endoplasmic Reticulum Stress; Gene Expression Regulation; Insulin Resistance; Kidney Diseases; Male; Obesity; Random Allocation; Rats; Rats, Wistar

2021
Odds and ends in psychopharmacology from the past 10 years.
    Journal of psychosocial nursing and mental health services, 2015, Volume: 53, Issue:1

    Topics: Acetamides; Anti-Obesity Agents; Antidepressive Agents; Central Nervous System Stimulants; Depression; Electroencephalography; History, 21st Century; Humans; Mifepristone; Obesity; Psychopharmacology; Stereoisomerism

2015